Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region

Arthritis & Rheumatism

Volumn 37, Issue 8, 1994, Pages 1212-1220

  Rubin, Laurence A ^a   Amos, Chris I ^b   Wade, Judith A ^a   Martin, John R ^c   Bale, Sherri J ^d   Little, A Hugh ^a   Gladman, Dafna D ^a   Bonney, George E ^e   Rubenstein, Joel D ^a   Siminovitch, Katherine A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TEXAS   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^e FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; ENVIRONMENTAL FACTOR; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; ALLELES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMAN; LINKAGE (GENETICS); MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGE; PEDIGREE; RECOMBINATION, GENETIC; RISK FACTORS; SPONDYLITIS, ANKYLOSING; SUPPORT, NON-U.S. GOV'T;

EID: 0027938087     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780370816     Document Type: Article

References (45)

1. Seronegative spondyloarthropathies
2. HLA‐B27 is necessary but not sufficient
3. Ankylosing spondylitis and HL‐A27
4. High association of HL‐A antigen, W27, with ankylosing spondylitis
5. The risk of developing ankylosing spondylitis in HLA–B27 positive individuals: a comparison of relatives of spondylitis patients with the general population
6. Epidemiology and genetics of ankylosing spondylitis
7. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls
8. Discordance between HLA‐B27 and ankylosing spondylitis: a family investigation
9. Spontaneous inflammatory disease in transgenic rats expressing HLA‐B27 and human B2 microglobulin
10. Genetics of non‐HLA marker genes in HLA‐B27‐positive and ‐negative ankylosing spondylitis families
11. Linkage analysis of “necessary” disease loci versus “susceptibility” loci
12. HLA–B27 haplotypes in family studies of ankylosing spondylitis
13. HLA class I typing by PCR: HLA‐B27 and an African B27 subtype
14. HLA‐DRW52‐associated DRB1 alleles: identification using polymerase chain reaction amplified DNA, sequence specific oligonucleotide probes, and chemiluminescent detection systems
15. HLA‐DR typing by PCR amplification with sequence specific primers (PCR‐SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantations
16. Strategies for multilocus linkage analysis in humans
17. A comparison of sib‐pair linkage tests for disease susceptibility loci
18. Bootstrap methods
19. HLA–Bw60 increases susceptibility to ankylosing spondylitis in HLA–B27+ patients
20. Inferring mode of inheritance by comparison of lod scores
21. Man bites dog? The validity of maximizing lod scores to determine mode of inheritance (editorial)
22. Familial versus sporadic ankylosing spondylitis: two different diseases
23. Effect of the germfree state on the inflammatory disease of HLA‐B27 transgenic rats: a split result (abstract)
24. Ankylosing spondylitis in families with two distinct B27 haplotypes: a selective association
25. Restriction fragment length polymorphism of the tumor necrosis factor region in patients with ankylosing spondylitis
26. Allelic variants of the human putative transporter involved in antigen processing
27. Linkage strategies for genetically complex traits. II. The power of affected relative pairs
28. Guilt by association: HLA‐B27 and ankylosing spondylitis
29. Immunogenetic basis of the seronegative spondyloarthropathies
30. Immunogenetics of spondyloarthropathies
31. Distribution of HLA‐B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules
32. Genetic modulation of antigen presentation by HLA‐B27 molecules
33. Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B (“45”) pocket of HLA‐B27
34. Genetics of ankylosing spondylitis, psoriatic arthritis, and Reiter's syndrome